| 233.07 Data as of May 22 |  +1.74 / +0.75%Today’s Change | 126.39 Today|||52-Week Range 238.83 | +59.23% Year-to-Date |
| Cramer's 'Mad Money' Recap: Ignore the Fed May 22 / TheStreet.com | Biogen's Hemophilia BLA Accepted - Analyst Blog May 20 / Zacks.com |
| Additional Patent for Acorda's Ampyra - Analyst Blog May 22 / Zacks.com | AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward May 16 / TheStreet.com |
| This Is Incredibly Bullish Behavior May 22 / TheStreet.com | Isis Gets $3.5M Milestone Payment - Analyst Blog May 14 / Zacks.com |
| Biogen Idec Stock Hits New 52-Week High (BIIB) May 22 / TheStreet.com | Elan seeks to weaken hostile bid with $1bn Theravance deal May 13 / FT.com |
| Positive Data on Novo Nordisk's N9-GP - Analyst Blog May 21 / Zacks.com |
| Previous close | 231.33 |
| Today’s open | 232.27 |
| Day’s range | -- - -- |
| Volume | 1,404,856 |
| Average volume (3 months) | 1,371,743 |
| Market cap | $54.9B |
| Dividend yield | -- |
| Earnings growth (last year) | +14.29% |
| Earnings growth (this year) | +23.19% |
| Earnings growth (next 5 years) | +17.80% |
| Revenue growth (last year) | +7.78% |
| P/E ratio | 37.0 |
| Price/Sales | 6.35 |
| Price/Book | 7.86 |
| Today’s change | Today’s % change | |
|---|---|---|
| BAXBaxter International... | -0.74 | -1.01% |
| AMGNAmgen Inc | +0.29 | +0.28% |
| GILDGilead Sciences Inc | -0.54 | -0.96% |
| LIFELife Technologies Co... | +0.42 | +0.57% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $1.91 |
| Annual revenue (last year) | $5.5B |
| Annual profit (last year) | $1.4B |
| Net profit margin | 25.18% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director George A. Scangos, PhD |
Chief Financial Officer & Executive Vice President Paul J. Clancy, MBA |
Corporate headquarters Weston, Massachusetts |
.
